Clinical Trial Update: Safety and Efficacy of Sentinel Node Biopsy Omission for Breast Cancer Patients Who Plan to Have Adjuvant Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the omission of sentinel node biopsy in breast cancer patients planning adjuvant chemotherapy has been withdrawn. No trial results or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Breast Cancer | Phase 2 | Status: WITHDRAWN